Publication: Rhabdomyolysis in a patient under treatment with sorafenib.
No Thumbnail Available
Identifiers
Date
2020
Authors
Díaz Alcázar, María Del Mar
Cervilla Sáez de Tejada, Eloísa
Ruiz Escolano, Elena
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
We present a case of rhabdomyolysis related to treatment with sorafenib in a patient with multifocal hepatocellular carcinoma. Rhabdomyolysis is a severe situation and potentially fatal. There are no laboratory data that can predict this condition. Early diagnosis is essential for prognosis. Rhabdomyolysis has been described as an adverse reaction of several drugs but it is not frequently related to sorafenib.
Description
MeSH Terms
Carcinoma, Hepatocellular
Humans
Liver Neoplasms
Prognosis
Rhabdomyolysis
Sorafenib
Humans
Liver Neoplasms
Prognosis
Rhabdomyolysis
Sorafenib